Page 13 - Mylan EpiPen Teaching Note

The following comments set the scene for assessing
Mylan’s pricing strategy:

“It's a kind of pay-or-die pricing system for the EpiPen.
Parents are really frantic about how they're going to pay for

this.”

Ralph Nader

“The cost of epinephrine is literally less than a Big Mac.”

Mark Baum, Pharmaceutical CEO developing an alternative

to EpiPen

Sometimes increased profits may not be worth as much as

they seem.

Or perhaps

‘Cheateth thy neighbor before he cheateth thee.’, Wallace

The value of these comments lies in the direction their

focus takes us. It is not simply a case of

cost – mark-up – price

but rather one of

Opportunity -greed – ethics and profit